Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02090114
Title RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistant (The RESTORE Study)
Acronym Restore
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Sibley Memorial Hospital Washington District of Columbia 20016 United States Details
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field